Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allyson Parry

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|June 21, 2018
Neurofibromatosis Type 2-Related Eye Disease Correlated With Genetic Severity TypeSally L Painter, Zuzana Sipkova, Beatrice Emmanouil, et al.
The Laryngoscope|November 20, 2023
Stereotactic Radiosurgery and Radiotherapy for Vestibular Schwannoma in NF2-Related SchwannomatosisManu Shrivastava, Beatrice Emmanouil, Rajeev Mathew, et al.
BMJ Open Quality|February 26, 2021
Alert Cards to improve awareness of an otological emergencyJoshua James Brown, Anne May, Rose Crabtree, et al.
Journal of Medical Genetics|August 30, 2017
Genetic Severity Score predicts clinical phenotype in NF2Dorothy Halliday, Beatrice Emmanouil, Pieter Pretorius, et al.
The Laryngoscope|November 21, 2018
Progression of hearing loss in neurofibromatosis type 2 according to genetic severityBeatrice Emmanouil, Rory Houston, Anne May, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|March 26, 2026
Inner Ear Schwannomas as a Risk Factor for Early Hearing Loss Independent of Vestibular Schwannoma Growth in NF2-related SchwannomatosisMarina Brimioulle, Pieter Pretorius, Nathaniel McHugh, et al.
Psycho-Oncology|April 30, 2019
Screening and intervening: Psychological distress in neurofibromatosis type 2 (NF2)Louise May Quarmby, Louise J Dalton, Rachel A Woolrich, et al.
Clinical Genetics|April 18, 2019
Trends in phenotype in the English paediatric neurofibromatosis type 2 cohort stratified by genetic severityDorothy Halliday, Beatrice Emmanouil, Grace Vassallo, et al.
Journal of Neurology|March 13, 2014
Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2Rosalie E Ferner, Adam Shaw, D Gareth Evans, et al.
Neuro-Oncology Practice|April 26, 2018
Bevacizumab in neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluationKatrina A Morris, John F Golding, Patrick R Axon, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|June 21, 2018
Neurofibromatosis Type 2-Related Eye Disease Correlated With Genetic Severity TypeSally L Painter, Zuzana Sipkova, Beatrice Emmanouil, et al.
The Laryngoscope|November 20, 2023
Stereotactic Radiosurgery and Radiotherapy for Vestibular Schwannoma in NF2-Related SchwannomatosisManu Shrivastava, Beatrice Emmanouil, Rajeev Mathew, et al.
BMJ Open Quality|February 26, 2021
Alert Cards to improve awareness of an otological emergencyJoshua James Brown, Anne May, Rose Crabtree, et al.
Journal of Medical Genetics|August 30, 2017
Genetic Severity Score predicts clinical phenotype in NF2Dorothy Halliday, Beatrice Emmanouil, Pieter Pretorius, et al.
The Laryngoscope|November 21, 2018
Progression of hearing loss in neurofibromatosis type 2 according to genetic severityBeatrice Emmanouil, Rory Houston, Anne May, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|March 26, 2026
Inner Ear Schwannomas as a Risk Factor for Early Hearing Loss Independent of Vestibular Schwannoma Growth in NF2-related SchwannomatosisMarina Brimioulle, Pieter Pretorius, Nathaniel McHugh, et al.
Psycho-Oncology|April 30, 2019
Screening and intervening: Psychological distress in neurofibromatosis type 2 (NF2)Louise May Quarmby, Louise J Dalton, Rachel A Woolrich, et al.
Clinical Genetics|April 18, 2019
Trends in phenotype in the English paediatric neurofibromatosis type 2 cohort stratified by genetic severityDorothy Halliday, Beatrice Emmanouil, Grace Vassallo, et al.
Journal of Neurology|March 13, 2014
Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2Rosalie E Ferner, Adam Shaw, D Gareth Evans, et al.
Neuro-Oncology Practice|April 26, 2018
Bevacizumab in neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluationKatrina A Morris, John F Golding, Patrick R Axon, et al.
Pageof 3